Sounds like they are doing something besides spending our money this time. Gonna get straight dope from the floor this year. Anxious this time as Sony is our target. Associate is great at reading people, good businessman.
Well, everybody wants a deal and they should be no different. Being in the same space and further along than we are should give them a dam good idea what it would take. The more institutional ownership we get the less we will have to say in the matter. They know where they are in development and where we are. Time will tell.
Unblinded too. Was looking for some data there. A little mid term noise on this front would do wonders.
Actually, the thing that bothers me most is the fact that a CEO of a competing company knew more about our tech and supply problems than our own CEO and gave us timelines that were ten times more accurate than our own Tokman. A guy from a company with a competing tech that knew ten times more than our own CEO. If that doesn't make you feel used and screwed, nothing will.
Warned by the message board experts. Very many times, and by several different seemingly informed posters. We don't even know who these people are. CEO's of competitors? Paid bashers perhaps? We look to the company for guidance and to set the record straight, not some dam message board. And every time questions were raised, Tokmen blew them off as meaningless. You look to the company to state where it is in terms of supply and advancements and business opportunities at hand and timelines. I can surely understand where alfin or whatever is coming from as I have invested on the company's guidance along with many others.
Back then many on this board called Tokman a liar and not afraid to embellish the truth and stretch things so far out of shape it became a bare faced lie, and many of us chose to believe Tokman. Bad mistake, you guys were right. A lot of water and money under the bridge. The only positives I see here now is that we are still afloat, great partner with money and engineering skills and a supplier to some of the greatest companies of our time. Remove Tokman and I wouldn't have anything to cast doubt MVIS. Now, I don't know how or why I got involved in this conversation and will end it here for me. Merry Christmas.
Wish I could say you will be wrong this time out, but the script never seems to change with Tokman. Just once, just once is all I want to see.
Everyone understands that. Wait for the picture to clear a bit. CES, hopefully will do that. UPS news is great as it should lead to competitors raising their eyes over a 15% disadvantage they are at. The tech is mature enough now, and we should see more soon. A multi year contract is on the horizon and that should do wonders in giving us insight into where we are going. Been here too long to get overly excited, but this is the best position this company has been in since I believed Alec Tokman, way back in 2009. Sony is the key.
Nope, not particularly important. Liking what I am seeing, at last. This is the kind of impact this tech can provide and we need. Let's take a turn for a change, it's time.
Certainly has the potential with the 20 patients they chose. Was looking for a Christmas gift here after the Roche thing last month. Hoping silence is not a bad thing.
That's all I've been asking for. Is Tokman approaching my one dream for MVIS? Tokman being right just once. Once in ten years. Just once for the home team. Once for the Christmas product he has us waiting for. Once for the loyal keeper of Bed D. Once for the longs to be able to say "now it's our turn" to the shorts. I dunno, another usual Christmas with Tokman????
I don't have a floor plan, but I seem to remember that MVIS and SNE are next to each other. Would be a real blow if Sony didn't give MVIS a big boost here. The pps would surely suffer, and we are not looking for that at all.
Yep, didn't do much for the pps but it did validate we are on the right road. Need help, hence, 3112 and now we wait. If all our vaccines go the same route it stretches out the time to market and an income stream. that is where we are right now and the street is waiting data. We need partnerships from big guns with experience with these adjuvants to help speed the process and ease the financials. Too hard to "go it alone" as the pumpers want to do and far too costly for the shareholders. Dr. Kim has to address these fronts in order to support the pps and attract big investors. I was looking for at least one more partnership this year and feel the Roche back step has other prospective partners holding off until that issue is understood. I feel the landscape has gotten a little rocky for Dr. Kim and I am looking for data to help him secure the partners he needs to make 2015 a much better year.